• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM
Click for more information
2.54% 30.3¢

IMMUTEP LIMITED - Corporate Spotlight

Market Cap $439.4M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
30.3¢ 		Change
0.008(2.54%) 		Mkt cap ! $439.4M
Open High Low Value Volume
30.0¢ 30.5¢ 30.0¢ $184.9K 610.3K

Buyers (Bids)

No. Vol. Price($)
27 452206 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 212873 16
View Market Depth
Last trade - 13.10pm 22/07/2024 (20 minute delay) ?
Last
30.0¢ 		  Change
0.008 ( 1.56 %)
Open High Low Volume
30.5¢ 30.5¢ 30.0¢ 295327
Last updated 13.27pm 22/07/2024 ?
IMM (ASX) Chart

Top Stories

Althea Group inks 'JV agreements' to boost marketing of cannabis-based beverage product in US market

Althea Group (ASX:AGH) has inked agreements "to establish [a] joint venture" with Flora Growth Corporation to make cannabis-based beverages.
High-grade copper results provide some relief to 29Metals after earlier mine shutdown 29Metals Ltd has reported positive results from a 3-hole program of drilling in Queensland, finding up to 4.8% copper.
Large fault structure and uranium anomalies picked up by Infini at Newfoundland play Infini Resources Ltd has revealed the presence of a large fault structure connected to anomalies at its Portland Creek uranium project.
Pure Hydrogen inks MOU for 5 hydrogen buses in Saigon – days after Twiggy's FFI reeled back in Pure Hydrogen has confirmed it's executed an MOU with a Vietnam-based entity to develop hydrogen-fuelled buses.
HBF to throw 10% vote behind NDC BidCo's buyout of Pacific Smiles Group Pacific Smiles Group has confirmed 10% shareholder HBF – the private health insurer – will vote in favour of PSQ's buyout by NDC BidCo.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.